[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"older-medical-patients\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:older-medical-patients":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100644538",false,"NCT07672132","Zinc Supplementation and Inflammation in Older Medical Patients","ZOOM IN Study: Micronutrient Deficiencies and Effect of Zinc Supplementation on Inflammation and Occurrence of Infections in Older Medical Patients (ZOOM) - A Sub-study of a Cluster Randomized Trial","ZOOM-IN","Inclusion Criteria:\n\n* above 65 years old included in ZOOM out ( clinical trials no: NCT07367412)\n* admittet at the medical emergency department Herlev Hospital\n\nExclusion Criteria:\n\n* Patients receiving zinc supplements (\\>10 mg daily) at time of inclusion\n* Patients with terminal illness (life expectancy \\\u003C 6 months, estimated by Clinical Frailty Scale ≥8)\n* Patients receiving parenteral nutrition (partial or complete)\n* Patients treated with hemodialysis or peritoneal dialysis\n* Patients known with severe dementia\n* Patients who do not understand Danish and patients with temporary civil person registration numbers (CPR)","ALL","65 Years",{"count":19,"type":20},220,"ESTIMATED","INTERVENTIONAL",[23],"NA","The hypothesis is that a daily supplement of 22 mg of zinc over 12 months can reduce in-flammatory biomarkers in acutely hospitalized older adults aged ≥ 65 years.\n\nThe aims are to determine, in acutely hospitalized older adults aged ≥ 65 years, if a daily supplement of 22 mg of zinc over 12 months compared to control can decrease inflammato-ry biomarkers, reduce symptoms of self-reported infection, reduce readmission and mortali-ty, increase QoL, increase physical performance, investigate potential adverse events to zinc supplement, and the changes in inflammatory biomarkers. It will also be studied if albumin-corrected zinc in plasma is a more accurate method for assessing zinc status than ordinary plasma zinc.",[26],"Older Medical Patients","NOT_YET_RECRUITING","2026-06-23",{"date":30,"type":31},"2026-06-26","ACTUAL",{"date":33,"type":20},"2026-06-02",{"date":35,"type":20},"2028-05-31",{"name":37,"class":38},"Herlev Hospital","OTHER",""]